Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Percentage held by non-affiliates Sale of Stock Available for Sale, Percentage Sale of Stock Available for Sale, Percentage Statistical Measurement [Domain] Statistical Measurement [Domain] Federal Income Tax Jurisdiction, Domestic Federal [Member] Title of 12(b) Security Title of 12(b) Security Schedule of Available-for-sale Securities [Table] Debt Securities, Available-for-Sale [Table] Subsequent event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount BOLSTER trial Bolster Trial [Member] Bolster Trial Financial Instrument [Axis] Financial Instrument [Axis] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Segment Reporting [Abstract] Schedule of Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Common stock, $0.001 par value, authorized 500,000,000 shares; issued 9,119,742 and 8,834,613 shares at June 30, 2026 and December 31, 2025, respectively; and outstanding, 9,119,004 and 8,833,875 shares at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Bonus payable if condition met, term Retention Bonus, Payable If Condition Met, Term Retention Bonus, Payable If Condition Met, Term Tax withholding payments on net share settlement equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Salaries, employee benefits and related taxes Employee-related Liabilities, Current Restatement Determination Date Restatement Determination Date Retention bonus Employee-related Liabilities Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Amendment Flag Amendment Flag Share based compensation expense Share Based Compensation Expense, General And Administrative Expense Share Based Compensation Expense, General And Administrative Expense Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Option to terminate Research Collaboration and License Agreement, Option to Terminate Research Collaboration and License Agreement, Option to Terminate Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Vested (in dollars per share) Weighted Average Exercise Price, Warrants Exercisable Weighted Average Exercise Price, Warrants Exercisable Other comprehensive gain (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Property, Plant, and Equipment [Abstract] Property, Plant, and Equipment [Abstract] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Cumulative translation adjustment arising during the period Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Assets: Assets, Fair Value Disclosure [Abstract] Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Basic shares (in shares) Weighted Average Number of Shares Outstanding, Basic Amortization/accretion on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Long-lived Assets Property, Plant and Equipment, Impairment [Policy Text Block] Number of tradeable contingent value rights Number of Tradeable Contingent Value Rights Number of Tradeable Contingent Value Rights Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Sublicensing fee Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Shares canceled (in shares) Investment Owned, Canceled, Shares Investment Owned, Canceled, Shares Entity Address, City or Town Entity Address, City or Town SAFE, discount rate SAFE, Discount Rate SAFE, Discount Rate Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Vested or expected to vest (in dollars per share) Weighted Average Exercise Price, Warrants Vested And Expected To Vest Weighted Average Exercise Price, Warrants Vested And Expected To Vest Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Software Software, Internally Developed and Purchased [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Outstanding, weighted average remaining contractual term (in years) Weighted Average Remaining Contractual Term warrant outstanding Weighted Average Remaining Contractual Term warrant outstanding Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Annual license maintenance fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Level 2 Fair Value, Inputs, Level 2 [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Total other comprehensive gain Other Comprehensive Income (Loss), Net of Tax Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] License License [Member] Number of stock issued (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Subsequent Event Type [Axis] Subsequent Event Type [Axis] Loss Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Segment Reporting Segment Reporting [Table Text Block] Non- Controlling Interest in Subsidiary Noncontrolling Interest [Member] Kuva Kuva [Member] Kuva Use of Estimates Use of Estimates, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Other Research And Development, Other [Member] Research And Development, Other Property and Equipment Property, Plant, and Equipment [Text Block] Greater than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Reversal in accrued bonus expense Restructuring and Related Activities, Reversal In Accrued Bonus Expense Restructuring and Related Activities, Reversal In Accrued Bonus Expense Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Unrecognized tax benefits Unrecognized Tax Benefits Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name New Jersey New Jersey Division of Taxation [Member] Treasury stock, at cost; 738 shares at June 30, 2026 and December 31, 2025 Treasury Stock, Common, Value Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Purchase of marketable securities Payments to Acquire Marketable Securities Technology Transfer Agreement [Abstract] Technology Transfer Agreement Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Potential milestone payments Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Segment Information Segment Reporting, Policy [Policy Text Block] Schedule of Property and Equipment Property, Plant, and Equipment [Table Text Block] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Income (Loss) Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Earnings Per Share [Abstract] Sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Company Selected Measure Name Company Selected Measure Name Sale of Stock, Name of Transaction [Domain] Sale of Stock [Domain] Schedule of Investments [Table] Schedule of Investments [Table] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Shares held by third party (in shares) Shares Held by Third Party Shares Held by Third Party Unrealized gain on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Payments to acquire Impilo SAFE Payments to Acquire Other Investments Income tax incentive receivable Income Tax Incentive Receivable Income Tax Incentive Receivable Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Warrants Warrant [Member] Diluted shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] ASCEND trial Ascend Trial [Member] Ascend Trial Useful life (in years) Property, Plant, and Equipment, Useful Life Underlying Security Market Price Change Underlying Security Market Price Change, Percent Net operating loss carryforwards Operating Loss Carryforwards Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Weighted Average Exercise Price, Warrants Outstanding Weighted Average Exercise Price, Warrants Outstanding Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Other Other General and Administrative Expense Award Timing Predetermined Award Timing Predetermined [Flag] Treasury Stock Treasury Stock, Common [Member] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Proceeds from exercise of warrants Proceeds from Warrant Exercises Effective income tax rate reconciliation Effective Income Tax Rate Reconciliation, Percent Expired (in shares) Warrants Expired, Shares Warrants Expired, Shares Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Debt Securities, Available-for-sale [Abstract] Debt Securities, Available-for-Sale [Abstract] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Vested or expected to vest (in shares) Vested and Expected to Vest, Shares Vested and Expected to Vest, Shares Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Vested or expected to vest, weighted average remaining contractual term (in years) Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Depreciation expense Depreciation Clinical department Clinical Department [Member] Clinical Department Antidilutive Securities [Axis] Antidilutive Securities [Axis] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Exclusive License and Collaboration Agreement Exclusive License and Collaboration Agreement [Member] Exclusive License and Collaboration Agreement Less than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Royalty Royalty [Member] Segment Information Segment Reporting [Text Block] Available-for-Sale-Securities Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Minimum Minimum [Member] Operating loss carryforwards, post acquisition Operating Loss Carryforwards, Post Acquisition Operating Loss Carryforwards, Post Acquisition Expiration Date Trading Arrangement Expiration Date Liabilities Liabilities [Abstract] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Outstanding, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Outstanding Aggregate Intrinsic Value, Warrants Outstanding Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Outstanding, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Business Combination [Line Items] Business Combination [Line Items] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Intangible asset, useful life Intangible Asset, Finite-Lived, Useful Life Vested, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Schedule of Restricted Stock Units Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount ATM Agreement At The Market Offering Agreement [Member] At The Market Offering Agreement Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segment [Domain] Segments [Domain] Property and Equipment Property, Plant, and Equipment [Policy Text Block] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Common Stock Warrants, Shares Common Stock Warrants, Shares Share-based compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Schedule of Classification of Available-for-Sale Securities Marketable Securities [Table Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Business Combination [Table] Business Combination [Table] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Estimated Fair Value Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract] Adoption Date Trading Arrangement Adoption Date Pre-determined development milestone method, revenue potential Pre-Determined Development Milestone Method, Revenue Potential Pre-Determined Development Milestone Method, Revenue Potential Counterparty Name [Domain] Counterparty Name [Domain] Total Lisata Therapeutics, Inc. stockholders' equity Equity, Attributable to Parent Total other income Other income, net Nonoperating Income (Expense) Vested, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Vested Aggregate Intrinsic Value, Warrants Vested ASSETS Assets [Abstract] Forfeited (in shares) Warrants Canceled, Shares Warrants Canceled, Shares Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Cost Debt Securities, Available-for-Sale, Amortized Cost Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Insider Trading Policies and Procedures [Line Items] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Basic and diluted loss per share EPS [Abstract] EPS Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Income tax refunds Proceeds from Income Tax Refunds Prepaid and other current assets Prepaid Expense and Other Assets, Current Weighted Average Remaining Contractual Term (Years) / Aggregate Intrinsic Value (In Thousands) Warrants Other Disclosures [Abstract] Warrants Other Disclosures Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Table] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Table] Business Combination [Domain] Business Combination [Domain] Research and Development Costs Research, Development, and Computer Software, Policy [Policy Text Block] Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Limitation on NOL carryforwards Limitation on Net Operating Loss Carryforwards Limitation on Net Operating Loss Carryforwards Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Common stock, value, outstanding Common Stock, Value, Outstanding Accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Corporate Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Business Combination [Axis] Business Combination [Axis] Equity [Abstract] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Income Statement [Abstract] Stockholders' Equity Equity, Attributable to Parent [Abstract] Document Transition Report Document Transition Report Schedule of Investments [Line Items] Schedule of Investments [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Investment, Name [Axis] Investment, Name [Axis] Operating Expenses: Operating Expenses [Abstract] Technology Transfer Agreement Technology Transfer Agreement [Text Block] Technology Transfer Agreement Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Cash and marketable securities Cash, Cash Equivalents, and Marketable Securities Cash, Cash Equivalents, and Marketable Securities Total fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Restricted Stock Restricted Stock [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Finance Finance, General And Administrative Expense Finance, General And Administrative Expense Name Forgone Recovery, Individual Name Expected weighted-average period in years of compensation cost to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Entity [Domain] Entity [Domain] Shares issued under license agreement (in shares) Shares Issued Under License Agreement Shares Issued Under License Agreement Investment income, net Investment Income, Net Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Accounts Receivable Accounts Receivable [Policy Text Block] Sale of stock available for sale Sale of Stock Available for Sale Sale of Stock Available for Sale Less - net income (loss) attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Weighted average estimated fair value of shares granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule Share-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Share-Based Compensation Share-Based Payment Arrangement [Text Block] Other assets Increase (Decrease) in Other Operating Assets Net proceeds from issuances of common stock (in shares) Stock issued (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Annual license maintenance fee, year seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven SAFE, valuation cap SAFE, Valuation Cap SAFE, Valuation Cap Loss on sale of NOL Loss On Sale of NOL Loss On Sale of NOL Proceeds from sale of NOLs, gross Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price COBRA coverage Restructuring and Related Activities, COBRA Payments Term Restructuring and Related Activities, COBRA Payments Term Total share-based compensation expense Share-Based Payment Arrangement, Expense Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Proceeds from option exercises (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised (in dollars per share) Weighted Average Exercise Price, Warrants Exercised Weighted Average Exercise Price, Warrants Exercised Weighted average estimated fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accumulated Deficit Retained Earnings [Member] Total operating expenses Operating Expenses Money market funds Money Market Funds [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Treasury Stock Stockholders' Equity, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Available for sale securities - net unrealized gain OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Common stock outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Lisata Therapeutics, Inc. common stockholders - diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Prepaid and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Amortization of intangible assets Intangible Asset, Finite-Lived, Amortization Expense Chemistry, manufacturing and controls Chemistry Manufacturing And Controls [Member] Chemistry Manufacturing And Controls Impilo Impilo [Member] Impilo Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Royalties, net of sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Financial Instruments [Domain] Financial Instruments [Domain] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Proceeds from option exercises Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Australian Taxation Office Australian Taxation Office [Member] Vested (in shares) Warrants, Vested Warrants, Vested Net proceeds from issuances of common stock Stock Issued During Period, Value, New Issues Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price State Income Tax Jurisdiction, Domestic State and Local [Member] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Line Items] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Line Items] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Schedule of Restricted Stock Nonvested Restricted Stock Shares Activity [Table Text Block] Computer equipment Computer Equipment [Member] Sale of Stock [Axis] Sale of Stock [Axis] Vested, weighted average remaining contractual term (in years) weighted Average Remaining Contractual Term, warrants vested weighted Average Remaining Contractual Term, warrants vested Weighted Average Remaining Contractual Term (Years) / Aggregate Intrinsic Value (In Thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Foreign Tax Authority Income Tax Jurisdiction, Foreign [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Operating loss Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Investment owned (in shares) Investment Owned, Balance, Shares Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Income Tax Holiday [Line Items] Income Tax Holiday [Line Items] Expected cost Restructuring and Related Cost, Expected Cost Investor relations/public relations/communications Communications and Information Technology Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Available-for-Sale Securities by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Schedule of Stock Options and Warrants Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Description of Business Business Description and Basis of Presentation [Text Block] Treasury stock (in shares) Treasury Stock, Common, Shares CEND CEND [Member] CEND Statement, Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Income from merger agreement Business Combination Acquisition Related Income Business Combination Acquisition Related Income Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Greater than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Reportable Segment Reportable Segment [Member] Reportable Segment Entity Small Business Entity Small Business Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Expired (in dollars per share) Weighted Average Exercise Price, Warrants Expired Weighted Average Exercise Price, Warrants Expired Subsequent Events [Abstract] Subsequent Events [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Milestones and Royalties Collaborative Arrangement, Accounting Policy [Policy Text Block] Other assets Other Assets, Noncurrent Document Type Document Type Vested or expected to vest, aggregate intrinsic value Aggregate Intrinsic Value, Warrants Vested And Expected To Vest Aggregate Intrinsic Value, Warrants Vested And Expected To Vest Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued liabilities Total Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Percentage of sublicensing revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Tax credit carryforward Tax Credit Carryforward, Amount Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Percentage of net sale Revenue, Performance Obligation, Percentage of Net Sale Revenue, Performance Obligation, Percentage of Net Sale Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Legal liabilities Legal Liabilities, Current Legal Liabilities, Current Impairment of non-financial asset Intangible Asset, Excluding Goodwill, Impairment Loss Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Consolidation Items [Axis] Consolidation Items [Axis] California California Franchise Tax Board [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Exercised (in shares) Warrants Exercised, Shares Warrants Exercised, Shares Net loss before benefit from income taxes and noncontrolling interests Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Vested or expected to vest, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Contingencies (Note 13) Commitments and Contingencies Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Computer equipment Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name [Axis] Counterparty Name [Axis] New York New York State Division of Taxation and Finance [Member] Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Furniture and fixtures Furniture and Fixtures [Member] LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Fair Value Measurements Fair Value Disclosures [Text Block] Variable consideration amounts, milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Level 3 Fair Value, Inputs, Level 3 [Member] Fair value market of tax NOLs Fair Value Market of Tax NOLs Fair Value Market of Tax NOLs Clinical and R&D related liabilities Clinical and Research And Development Related Liabilities, Current Clinical and Research And Development Related Liabilities, Current Vested, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term Revenue from collaborative arrangement Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer PEO Name PEO Name Aggregate offering amount authorized per agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Contract with customer, liability Contract with Customer, Liability Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Research tax credit rate Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Legal Entity [Axis] Legal Entity [Axis] Accounts payable, accrued liabilities and other liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Outstanding stock threshold Outstanding Stock Threshold Outstanding Stock Threshold Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Weighted Average Exercise Price Warrants Weighted Average Exercise Price [Roll Forward] Warrants Weighted Average Exercise Price [Roll Forward] Accounting & tax consulting liabilities Accrued Professional Fees, Current Other Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Subsequent Event [Table] Subsequent Event [Table] Ownership percentage Equity Method Investment, Ownership Percentage Share-based compensation Share-Based Payment Arrangement, Noncash Expense Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Proceeds from warrant exercise (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Investment, Name [Domain] Investment, Name [Domain] Lisata Therapeutics, Inc. common stockholders- basic (in dollars per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Estimated Fair Value Total Total Cash equivalents Debt Securities, Available-for-Sale Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Forfeited (in dollars per share) Weighted Average Exercise Price, Warrants Canceled Weighted Average Exercise Price, Warrants Canceled Granted (in dollars per share) Weighted Average Exercise Price, Warrants Granted Weighted Average Exercise Price, Warrants Granted Workforce reduction Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Sanford Burnham Prebys Sanford Burnham Prebys [Member] Sanford Burnham Prebys Lisata Lisata [Member] Lisata Equity Awards Adjustments Equity Awards Adjustments [Member] License Agreements Research Collaboration and License Agreements Collaborative Arrangement Disclosure [Text Block] Total liabilities, non-controlling interests and stockholders' equity Liabilities and Equity Business development Business Development Intangible Asset Intangible Assets, Finite-Lived, Policy [Policy Text Block] Stock options Share-Based Payment Arrangement, Option [Member] Non-controlling interests Equity, Attributable to Noncontrolling Interest Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Income Tax Authority [Domain] Income Tax Jurisdiction [Domain] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Other income (expense), net Other Nonoperating Income (Expense) Total Lisata Therapeutics, Inc. Stockholders' Equity Parent [Member] Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative General and Administrative Expense Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Proceeds from warrant exercise Stock Issued During Period, Value, Conversion of Convertible Securities Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Legal Legal, General And Administrative Expense Legal, General And Administrative Expense Adjustment to Compensation: Adjustment to Compensation [Axis] Granted (in shares) Warrants Granted, Shares Warrants Granted, Shares Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Assets, fair value Assets, Fair Value Disclosure Income Tax Authority [Axis] Income Tax Jurisdiction [Axis] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] In-process Research and Development Expense In Process Research and Development, Policy [Policy Text Block] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Proceeds from sale of NOLs Proceeds From Sale of NOLS Proceeds From Sale of NOLS Australia Research and Development Tax Incentive Research and Development Tax Incentive [Text Block] Research and Development Tax Incentive Base salary period for termination compensation Restructuring and Related Activities, Compensation Amount, Base Salary Period Restructuring and Related Activities, Compensation Amount, Base Salary Period Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Company Selected Measure Amount Company Selected Measure Amount Vested or expected to vest, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Share-based compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Price per share of the common stock acquired (in dollars per share) Business Combination, Price Per Share Termination fee Termination Fee Under Merger Agreement Termination Fee Under Merger Agreement Non-PEO NEO Non-PEO NEO [Member] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Benefit from income taxes Income Tax Expense (Benefit) Award Timing Method Award Timing Method [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Termination of contract, lapse of payment Termination of Contract, Lapse of Payment Termination of Contract, Lapse of Payment Research and development Research and Development Expense (Excluding Acquired in Process Cost) Qilu Qilu [Member] Qilu Net loss attributable to Lisata Therapeutics, Inc. common stockholders Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Location, Statement of Financial Position, Balance [Axis] Location, Statement of Financial Position, Balance [Axis] Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from exercise of options Proceeds from Stock Options Exercised Value of stock issued Stock Issued During Period, Value, Restricted Stock Award, Gross Contingent Value Rights (CVRs) Contingent Value Rights (CVRs) [Member] Contingent Value Rights (CVRs) Income Tax Holiday [Table] Income Tax, Holiday [Table] Number of contractual right to receive for contingent cash payments Number Of Contractual Right To Receive For Contingent Cash Payments Number Of Contractual Right To Receive For Contingent Cash Payments Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]